The findings suggest that DPP4 plays a pivotal role in modulating immune responses and gut physiology, with its elevated activity linked to dysbiosis, exacerbated inflammation, and disease progression in IBD. The gene discussed is DPP4; the disease is inflammatory bowel disease.